COSCIENS Biopharma Inc T.CSCI

Alternate Symbol(s): CSCI

Healthcare Biotechnology

COSCIENS Biopharma Inc., formerly Aeterna Zentaris Inc., is a specialty biopharmaceutical company engaged in the development and commercialization of a diverse portfolio of pharmaceutical and diagnostic products, including those focused on areas of unmet medical need. Its lead product, macimorelin (Macrilen; Ghryvelin), is an oral test indicated for the diagnosis of adult growth hormone deficiency (AGHD). The Company is also engaged in the development of therapeutic assets and proprietary extraction technology, which is applied to the production of active ingredients from renewable plant resources used in cosmeceutical products (i.e., oat beta glucan and avenanthramides, which are found in skincare product brands like Aveeno and Burt’s Bees formulations) and being developed as potential nutraceuticals and/or pharmaceuticals.

TSX:CSCI - Post by User

COSCIENS Biopharma Inc

<< Previous

Bullboard Posts

Next >>

Post by prophetoffactzon Nov 20, 2024 8:15pm

53 Views

Post# 36322870

Avenanthramide

What happened to avenanthramide sales? One possibility is that the amount if avenanthramide was changed after the spin-off from J&J. This could create an opportunity for Juvente.

Perplexity Ai:

Yes, Kenvue has changed the formulation of some Aveeno products since being spun off from Johnson & Johnson

3

5

. The Daily Moisturising Lotion formula was recently modified, with users noting increased petroleum content and different absorption properties

3

. Aveeno's website acknowledges packaging updates but claims the "same nourishing formula" remains

5

, though user experiences suggest otherwise. Some consumers have reported skin irritation and flare-ups with the new formula that they did not experience with the original version